MMP9 and familial pancreatic carcinoma: In contrast to these studies, one group reported decreased invasion capacity of pancreatic cancer cells in vitro upon PPARβ/δ activation with GW501516 as well as downregulated prometastatic Matrix metalloproteinase-9 (MMP9) expression [129].